2022. Method Development And Validation For The Torsemide In Tablet Dosage Form By Rp-Hplc. Journal of Pharmaceutical Negative Results. (Dec. 2022), 2365–2370. DOI:https://doi.org/10.47750/pnr.2022.13.S04.292.